vs
Side-by-side financial comparison of Relay Therapeutics, Inc. (RLAY) and UNITED SECURITY BANCSHARES (UBFO). Click either name above to swap in a different company.
UNITED SECURITY BANCSHARES is the larger business by last-quarter revenue ($13.5M vs $7.0M, roughly 1.9× Relay Therapeutics, Inc.). UNITED SECURITY BANCSHARES produced more free cash flow last quarter ($19.8M vs $-235.9M).
Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.
United Security Bancshares is a bank holding company headquartered in Fresno, California. It operates 11 branches.
RLAY vs UBFO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.0M | $13.5M |
| Net Profit | — | $3.4M |
| Gross Margin | — | — |
| Operating Margin | — | 31.5% |
| Net Margin | — | 25.2% |
| Revenue YoY | — | 13.6% |
| Net Profit YoY | — | 36.8% |
| EPS (diluted) | — | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.0M | $13.5M | ||
| Q3 25 | $0 | $14.0M | ||
| Q2 25 | — | $12.6M | ||
| Q1 25 | $7.7M | $13.7M | ||
| Q4 24 | $0 | $11.9M | ||
| Q3 24 | $0 | $13.8M | ||
| Q2 24 | $0 | $13.0M | ||
| Q1 24 | $10.0M | $12.8M |
| Q4 25 | — | $3.4M | ||
| Q3 25 | $-74.1M | $4.0M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | $-77.1M | $2.7M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | $-88.1M | $3.8M | ||
| Q2 24 | $-92.2M | $4.3M | ||
| Q1 24 | $-81.4M | $4.2M |
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 40.3% | ||
| Q2 25 | — | 24.0% | ||
| Q1 25 | -1105.2% | 27.5% | ||
| Q4 24 | — | 27.5% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 46.4% | ||
| Q1 24 | -903.0% | 45.9% |
| Q4 25 | — | 25.2% | ||
| Q3 25 | — | 28.7% | ||
| Q2 25 | — | 17.2% | ||
| Q1 25 | -1003.6% | 19.6% | ||
| Q4 24 | — | 20.9% | ||
| Q3 24 | — | 27.7% | ||
| Q2 24 | — | 33.0% | ||
| Q1 24 | -813.3% | 32.6% |
| Q4 25 | — | $0.18 | ||
| Q3 25 | $-0.43 | $0.23 | ||
| Q2 25 | — | $0.13 | ||
| Q1 25 | $-0.46 | $0.16 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | $-0.63 | $0.22 | ||
| Q2 24 | $-0.69 | $0.25 | ||
| Q1 24 | $-0.62 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $84.0M | $264.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $567.1M | $139.7M |
| Total Assets | $621.3M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $84.0M | $264.2M | ||
| Q3 25 | $91.6M | $211.1M | ||
| Q2 25 | — | $199.5M | ||
| Q1 25 | $93.5M | $198.4M | ||
| Q4 24 | $124.3M | $216.9M | ||
| Q3 24 | $152.4M | $216.8M | ||
| Q2 24 | $134.1M | $166.3M | ||
| Q1 24 | $152.9M | $168.6M |
| Q4 25 | $567.1M | $139.7M | ||
| Q3 25 | $607.7M | $137.4M | ||
| Q2 25 | — | $134.3M | ||
| Q1 25 | $721.1M | $132.9M | ||
| Q4 24 | $777.8M | $130.4M | ||
| Q3 24 | $838.9M | $132.9M | ||
| Q2 24 | $681.7M | $127.3M | ||
| Q1 24 | $745.8M | $124.2M |
| Q4 25 | $621.3M | $1.2B | ||
| Q3 25 | $670.0M | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | $799.4M | $1.2B | ||
| Q4 24 | $871.3M | $1.2B | ||
| Q3 24 | $930.1M | $1.3B | ||
| Q2 24 | $772.5M | $1.2B | ||
| Q1 24 | $841.4M | $1.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-235.5M | $22.1M |
| Free Cash FlowOCF − Capex | $-235.9M | $19.8M |
| FCF MarginFCF / Revenue | -3370.0% | 146.0% |
| Capex IntensityCapex / Revenue | 5.9% | 16.8% |
| Cash ConversionOCF / Net Profit | — | 6.46× |
| TTM Free Cash FlowTrailing 4 quarters | $-622.7M | $36.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-235.5M | $22.1M | ||
| Q3 25 | $-62.1M | $7.0M | ||
| Q2 25 | — | $8.7M | ||
| Q1 25 | $-73.2M | $3.0M | ||
| Q4 24 | $-249.1M | $19.6M | ||
| Q3 24 | $-75.1M | $5.4M | ||
| Q2 24 | $-65.8M | $2.3M | ||
| Q1 24 | $-50.3M | $7.4M |
| Q4 25 | $-235.9M | $19.8M | ||
| Q3 25 | $-62.1M | $6.1M | ||
| Q2 25 | — | $8.1M | ||
| Q1 25 | $-73.6M | $2.9M | ||
| Q4 24 | $-251.1M | $18.6M | ||
| Q3 24 | $-75.3M | $5.3M | ||
| Q2 24 | $-65.8M | $2.0M | ||
| Q1 24 | $-52.1M | $7.0M |
| Q4 25 | -3370.0% | 146.0% | ||
| Q3 25 | — | 43.7% | ||
| Q2 25 | — | 64.3% | ||
| Q1 25 | -958.4% | 21.2% | ||
| Q4 24 | — | 156.0% | ||
| Q3 24 | — | 38.1% | ||
| Q2 24 | — | 15.5% | ||
| Q1 24 | -520.7% | 54.8% |
| Q4 25 | 5.9% | 16.8% | ||
| Q3 25 | — | 6.0% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | 5.0% | 0.9% | ||
| Q4 24 | — | 8.7% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | 17.8% | 3.6% |
| Q4 25 | — | 6.46× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | — | 4.01× | ||
| Q1 25 | — | 1.13× | ||
| Q4 24 | — | 7.87× | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | — | 1.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
